IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PIZZI, Marina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.595
EU - Europa 6.414
AS - Asia 2.103
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 12
AF - Africa 10
AN - Antartide 1
Totale 16.169
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.560
PL - Polonia 3.222
CN - Cina 1.236
UA - Ucraina 1.023
DE - Germania 628
IT - Italia 544
FI - Finlandia 262
HK - Hong Kong 255
GB - Regno Unito 252
IN - India 232
SG - Singapore 185
IE - Irlanda 173
FR - Francia 155
VN - Vietnam 126
RU - Federazione Russa 45
BE - Belgio 37
CA - Canada 32
SE - Svezia 27
CZ - Repubblica Ceca 25
TR - Turchia 23
EU - Europa 16
AU - Australia 15
IR - Iran 14
KR - Corea 14
NL - Olanda 8
CL - Cile 6
MU - Mauritius 6
BR - Brasile 4
ES - Italia 4
JP - Giappone 4
RO - Romania 4
IL - Israele 3
NZ - Nuova Zelanda 3
EE - Estonia 2
ET - Etiopia 2
GE - Georgia 2
ID - Indonesia 2
MX - Messico 2
PK - Pakistan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
CH - Svizzera 1
GR - Grecia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
JM - Giamaica 1
KE - Kenya 1
MK - Macedonia 1
OM - Oman 1
ZA - Sudafrica 1
Totale 16.169
Salva come PNG Salva come JPEG
Città #
Warsaw 3.222
Fairfield 1.040
Woodbridge 812
Jacksonville 732
Houston 601
Ashburn 539
Ann Arbor 491
Chandler 474
Cambridge 441
Seattle 394
Wilmington 383
Princeton 314
Nanjing 298
Brescia 254
Hong Kong 252
Dearborn 206
Beijing 205
Dublin 172
New York 162
Helsinki 147
Dong Ket 126
Singapore 94
Nanchang 89
Pune 81
Shenyang 78
Des Moines 76
Hebei 71
Jinan 64
Lancaster 62
Tianjin 59
Changsha 56
Shanghai 54
San Diego 48
Milan 45
Brussels 35
Los Angeles 31
London 30
Jiaxing 29
Kunming 29
Ningbo 28
Munich 23
Zhengzhou 23
Taizhou 22
Hangzhou 21
Lanzhou 21
Toronto 20
Brno 19
San Francisco 19
Verona 19
Boardman 18
Orange 18
Guangzhou 17
Haikou 17
San Mateo 16
Phoenix 15
Augusta 13
Kocaeli 13
Norwalk 13
San Giuliano Milanese 13
Kilburn 12
Leawood 11
Ardabil 10
Taiyuan 9
Mumbai 8
Nürnberg 8
Ottawa 8
Pavia 8
Rome 8
Melbourne 7
Chions 6
Monmouth Junction 6
Olomouc 6
Oxford 6
Cattolica 5
Changchun 5
Clifton 5
Falls Church 5
La Spezia 5
Napoli 5
Paris 5
San Donà Di Piave 5
Seoul 5
Chicago 4
Corridonia 4
Hefei 4
New Bedfont 4
Alzano Lombardo 3
Auckland 3
Bergamo 3
Berlin 3
Birmingham 3
Canberra 3
Central 3
Chiswick 3
Frankfurt am Main 3
Fulda 3
Gunzenhausen 3
Islington 3
Redwood City 3
Rho 3
Totale 12.880
Salva come PNG Salva come JPEG
Nome #
CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid 306
Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation 271
PEA and luteolin synergistically reduce mast cell-mediated toxicity and elicit neuroprotection in cell-based models of brain ischemia 264
Glutamatergic neurons induce expression of functional glutamatergic synapses in primary myotubes. 260
Glutamatergic Reinnervation and Assembly of Glutamatergic Synapses in Adult Rat Skeletal Muscle Occurs at Cholinergic Endplates 247
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 247
Glutamatergic reinnervation through peripheral nerve graft dictates assembly of glutamatergic synapses at rat skeletal muscle 246
1B/(-)IRE DMT1 Expression during Brain Ischemia Contributes to Cell Death Mediated by NF-κB/RelA Acetylation at Lys310 235
The End Is the Beginning: Parkinson's Disease in the Light of Brain Imaging 227
NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases 225
NF-κB and epigenetic mechanisms as integrative regulators of brain resilience to anoxic stress. 223
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 220
Priming of cultured neurons with sabeluzole results in long-lasting inhibition of neurotoxin-induced tau expression and cell death. 219
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice. 215
Synergistic association of valproate and resveratrol reduces brain injury in ischemic stroke 215
Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window. 212
Mild inflammatory profile without gliosis in the c-rel deficient mouse modeling a late-onset parkinsonism 211
Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model 208
A Polyphenol-Enriched Supplement Exerts Potent Epigenetic-Protective Activity in a Cell-Based Model of Brain Ischemia 199
Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation 197
Pharmacological targeting of the beta-amyloid precursor protein intracellular domain 172
Mitochondria and alpha-synuclein: Friends or foes in the pathogenesis of Parkinson's disease? 170
NUOVO IMPIEGO TERAPEUTICO PREVENTIVO DELLA SUBUNITA' C-REL DELLA PROTEINA NF-KAPPAB E NUOVO IMPIEGO DI UN ANIMALE TRASGENICO NON UMANO CHE PORTA LA DELEZIONE DEL GENE C-REL (C-REL-/-) 161
The gamma-Secretase Modulator CHF5074 Reduces the Accumulation of Native Hyperphosphorylated Tau in a Transgenic Mouse Model of Alzheimer's Disease 154
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 153
Spinal cord mGlu1a receptors - Possible target for amyotrophic lateral sclerosis therapy 147
Targeting IKK2 by pharmacological inhibitor AS602868 prevents excitotoxic injury to neurons and oligodendrocytes. 147
Post-ischemic brain damage: NF-kappaB dimer heterogeneity as a molecular determinant of neuron vulnerability 143
NF-kappaB p50/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia. 142
c-Rel deficient mice, a mouse model of "spreading" PD-like pathology. 142
Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemia. 141
The Role of Mast Cells in Stroke 141
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 140
NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in mice 136
Chapter 24 NF-KappaB Dimers in the Regulation of Neuronal Survival 133
A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release. 126
N-methyl-D-aspartate neurotoxicity in hippocampal slices: protection by aniracetam. 124
A Tau antisense oligonucleotide decreases neurone sensitivity to excitotoxic injury. 122
Cellular mechanisms for neurotensin receptor-mediated release of prolactin. 122
Activation of dopamine D2 receptors linked to voltage-sensitive potassium channels reduces forskolin-induced cyclic AMP formation in rat pituitary cells. 121
Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line 117
Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration. 117
Inhibition of glutamate-induced neurotoxicity by a tau antisense oligonucleotide in primary culture of rat cerebellar granule cells 112
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 112
Activation of multiple metabotropic glutamate receptor subtypes prevents NMDA-induced excitotoxicity in rat hippocampal slices. 111
Pharmacological basis for dopamine D-2 receptor diversity 109
The gamma-secretase modulator CHF5074 elicits neuroprotection and increases histone acetylation in primary cortical neurons exposed to oxygen glucose deprivation 108
Synapsin III alterations in Parkinson's disease 108
Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. 106
Electrophysiological and metabolic effects of CHF5074 in the hippocampus: protection against in vitro ischemia. 106
Synergistic association of valproate and resveratrol reduces brain injury in ischemic stroke. 106
Tolerance to hypoactivity and sensitization to hyperactivity after chronic treatment with a presynaptic dose of lisuride in rats 105
Mitochondrial Dysfunction and Alpha-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First? 104
SYNERGIC ROLE OF RESVERATROL AND HDACi MS-275 IN NEUROPROTECTION 103
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons 103
The differential coupling mechanism of dopamine D-2 receptor subtypes: importance for the actions of neuroleptic drugs 102
c-Rel deficient mice, a mouse model of “spreading” PD-like pathology 102
Post-synaptic D1 and D2 dopamine receptors are present in rabbit renal and mesenteric arteries 101
Repeated administration of (−) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions 101
Various Ca2+ entry blockers prevent glutamate-induced neurotoxicity. 101
Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices. 100
Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices 99
Cortical neurons induce the expression of glutamate receptors in primary myotubes 99
Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol. 99
Differential expression of fetal and mature tau isoforms in primary cultures of rat cerebellar granule cells during differentiation in vitro 99
Spinal cord mGlu1a receptors: possible target for amyotrophic lateral sclerosis therapy. 99
EXACERBATED AGE-DEPENDENT LOSS OF NIGRAL DOPAMINERGIC NEURONS IN NF-KAPPAB C-REL -/- MICE 99
Properties of benzodiazepine binding sites in peripheral blood lymphocytes 98
Lack of vasoactive intestinal peptide-releasing property in prolactin cells from ovariectomized rats: contribution of post-transductional impairments 98
Inhibition of IκBα phosphorylation prevents glutamate-induced NF-κB activation and neuronal cell death 97
Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells. 97
Opposing regulation of amyloid precursor protein by ionotropic and metabotropic glutamate receptors. 96
The inhibitor of IkappaBalpha phosphorylation BAY 11-7082 prevents NMDA neurotoxicity in mouse hippocampal slices. 96
Differential pattern of expression of G proteins in nucleus striatum from 6-hydroxydopamine lesioned rats. 96
Degenerazione età –dipendente dei neuroni dopaminergici della sostanza nera nei topi NF-kappaB cRel 94
An in vitro method of diagnosing Parkinson's disease 93
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 92
Differential expression of fetal and mature tau isoforms in primary cultures of rat cerebellar granule cells during differentiation in vitro. 91
A bioinformatics analysis of memory consolidation reveals involvement of the transcription factor c-rel. 91
Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells. 91
Neuroprotection by metabotropic glutamate receptor agonists on kainate-induced degeneration of motor neurons in spinal cord slices from adult rat. 91
Peripheral and central mechanisms of action of serotoninergic anorectic drugs. 91
Glutamatergic innervation of rat skeletal muscle by supraspinal neurons: a new paradigm in spinal cord injury repair 89
Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation 89
Differential up-regulation of D-1 and D-2 dopamine receptor function in mesostriatal areas but not in cortical-limbic brain regions of rats chronically treated with (?)sulpiride and SCH 23390 89
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 88
Group-I metabotropic glutamate receptors: hypotheses to explain their dual role in neurotoxicity and neuroprotection. 85
Acetylation of NF-kappaB p50/RelA and histones in the epigenetic regulation of pro-apoptotic transcription: a neuroprotective target in brain ischemia 85
Molecular mechanisms of glutamate-induced neurodegeneration 85
Reversal of glutamate excitotoxicity by activation of PKC-associated metabotropic glutamate receptors in cerebellar granule cells relies on NR2C subunit expression 84
Possible new targets for GPCR modulation: allosteric interactions, plasma membrane domains, intercellular transfer and epigenetic mechanisms 82
The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury. 81
Evidence for the presence of D2 but not D1 dopamine receptors in rat hypothalamic perifornical area. 81
Targeting epigenetic regulation of NF-KappaB and histones in the therapy of post-ischemic brain injury 78
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionate and kainate differently affect neuronal cytoarchitecture of rat cerebellar granule cells 77
Leptin Is Induced in the Ischemic Cerebral Cortex and Exerts Neuroprotection Through NF-{kappa}B/c-Rel-Dependent Transcription. 76
Parkinson's disease: from synaptic loss to connectome dysfunction 76
Leptin increases axonal growth cone size in developing mouse cortical neurons by convergent signals inactivating glycogen synthase kinase-3beta. 75
ACETYLATION OF NF-KAPPAB p65 IN THE EPIGENETIC REGULATION OF TRANSCRIPTION: A NEUROPROTECTIVE TARGET IN BRAIN ISCHEMIA 75
Dopamine D2 receptor stimulation decreases the inositol trisphosphate level of rat striatal slices 75
Totale 13.194
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.124
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.124
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.269 0 219 214 430 311 576 451 529 345 714 219 261
2020/20212.949 94 320 98 362 120 293 190 336 404 267 279 186
2021/20221.396 121 272 25 37 25 64 87 77 70 181 129 308
2022/20231.311 187 34 56 102 134 329 3 132 192 27 58 57
2023/20241.384 92 34 120 82 68 325 55 66 276 31 33 202
2024/202562 24 38 0 0 0 0 0 0 0 0 0 0
Totale 16.724